Iovance is pursuing accelerated approval in advanced melanoma for the tumour inf...
Faced with such a disappointing approval number last year, manufacturers hope fo...
National Resilience expects the expanded capacity will help in securing the supp...
According to GlobalData’s Drugs database, early-stage therapies are focused on v...
Joenja’s approval was based on the data obtained from a Phase II/III clinical tr...
Former surgeon general Jerome Adams has emerged as a leading voice on public hea...
Calquence’s conditional approval was based on the data from the Phase II ACE-LY-...
The US biosimilars market is notably underdeveloped and biosimilar entry in the ...
The new facility will increase the company’s current Narita plasma manufacturing...
A century after the success of the BCG vaccine, scientists are still searching f...
The collaboration will expand the platform application of each company through d...
In a setback to GSK, a California judge ruled that a consumer cleared a key lega...
Publication of forthcoming European Union pharmaceutical legislation has been po...
Monday marked the 20th anniversary of the Iraq war, which resulted in an estimat...
At this Massachusetts health system, "digital access coordinators" are standing ...
This change is coming just as telepsychiatry has made mental health care, includ...
